Ian Hunneyball has been appointed president of discovery services by drug discovery firm Evotec OAI.

He will lead the chemistry operations in Abingdon and the biology services in Hamburg, Germany.

Evotec OAI has created the position because of increasing demand for integrated services covering all biology and chemistry aspects of drug discovery.